:

Wanxian Xu1, Tao Zhang2, Zhitao Zhu3

  • 1Department of Breast and Thyroid Surgery, First People's Hospital of Kunming City and Calmette Affiliated Hospital of Kunming Medical University, Panglong District, Kunming, Yunnan.

概括

两个免疫细胞表型,CD3在CD28+CD4-CD8-T细胞上和HLA DR在CD33-HLA DR+上,显示出对乳腺癌 (BC) 的保护作用. 这些发现支持BC治疗的潜在新治疗点.